INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed Incorporated – INSM

NEW YORK, NY / ACCESS Newswire / December 27, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Insmed Incorporated ("Insmed" or the "Company") (NASDAQ: INSM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Insmed and certain of its officers and/or directors […]

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XOMA Royalty Corporation – XOMA

NEW YORK, NY / ACCESS Newswire / December 27, 2025 / Pomerantz LLP is investigating claims on behalf of investors of XOMA Royalty Corporation ("Xoma" or the "Company") (NASDAQ: XOMA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Xoma and certain of its officers and/or

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Above Foods Ingredients Inc. – ABVE

NEW YORK, NY / ACCESS Newswire / December 27, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Above Foods Ingredients Inc. ("Above Food" or the "Company") (NASDAQ: ABVE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Above Food and certain of

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ramaco Resources, Inc. – METC

NEW YORK, NY / ACCESS Newswire / December 27, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Ramaco Resources, Inc. ("Ramaco" or the "Company") (NASDAQ: METC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Ramaco and certain of its officers and/or

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation – TNDM

NEW YORK CITY, NY / ACCESS Newswire / December 27, 2025 / WHY: New York, N.Y., December 27, 2025. Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Tandem Diabetes Care, Inc.(NASDAQ:TNDM) resulting from allegations that Tandem Diabetes Care may have issued materially misleading

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cogent Communications Holdings, Inc. – CCOI

NEW YORK, NY / ACCESS Newswire / December 27, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Cogent Communications Holdings, Inc. ("Cogent" or the "Company") (NASDAQ:CCOI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Cogent and certain of its officers and/or

Senvest Capital Inc. Announces Death of Chief Executive Officer and Chairman of the Board

(TSX:SEC), MONTREAL, Dec. 27, 2025 (GLOBE NEWSWIRE) — Senvest Capital Inc. (the “Corporation” or “Senvest”) (TSX: SEC) announces with profound sadness the passing of its founder and long-time leader, Victor Mashaal, who served as President, Chief Executive Officer, and Chairman of the Board of Directors. Victor passed away at the age of 87 following a

Senvest Capital Inc. Announces Death of Chief Executive Officer and Chairman of the Board

Senvest Capital Inc. Announces Death of Chief Executive Officer and Chairman of the Board GlobeNewswire December 27, 2025 MONTREAL, Dec. 27, 2025 (GLOBE NEWSWIRE) — Senvest Capital Inc. (the “Corporation” or “Senvest”) (TSX: SEC) announces with profound sadness the passing of its founder and long-time leader, Victor Mashaal, who served as President, Chief Executive Officer,

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Charming Medical Limited- MCTA

NEW YORK, NY / ACCESS Newswire / December 27, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Charming Medical Limited ("Charming Medical" or the "Company") (NASDAQ:MCTA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Charming Medical and certain of its officers

Scroll to Top